CAS: 1669444-50-1
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
PF 05214030 REF: 3D-BP180194CAS: 1669444-50-1 | Min. 95% | 440.00 €~1,739.00 € | Wed 18 Dec 24 | |
PF-05214030 REF: TM-T70299CAS: 1669444-50-1 | - - - | 1,437.00 €~2,364.00 € | Mon 27 Jan 25 |
PF 05214030
CAS:1669444-50-1
PF 05214030 is an investigational drug that has been shown to reduce the number of …
Formula:
C17H13Cl2FN2O4S
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
431.3 g/mol
Ref: 3D-BP180194
1mg | 440.00 € | ||
2mg | 626.00 € | ||
5mg | 969.00 € | ||
10mg | 1,403.00 € | ||
25mg | 1,739.00 € |
Estimated delivery in United States, on Wednesday 18 Dec 2024
PF-05214030
CAS:1669444-50-1
PF-05214030 is a novel potent TRPV4 antagonist (hTRPV4 IC50 4nM; rTRPV4 IC50 27nM).
Formula:
C17H13Cl2FN2O4S
Color and Shape:
Liquid
Molecular weight:
431.27
Ref: TM-T70299
25mg | 1,437.00 € | ||
50mg | 1,872.00 € | ||
100mg | 2,364.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025